✦ LIBER ✦

Aripiprazole as an Augmentation Agent in Treatment-Resistant Body Dysmorphic Disorder

✍ Scribed by Dr Özcan Uzun, Barbaros Özdemir

Book ID: 119930909
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 30
Category: Article
ISSN: 1179-1918
DOI: 10.2165/11536730-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of triiodothyronine as an augmen

The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS

✍ Tammas Kelly; Daniel Z. Lieberman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Acetylsalicylic acid as an augmentation

Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats

✍ Ying Wang; Feng Yang; Yang-Feng Liu; Fei Gao; Wen Jiang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 796 KB

EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN

EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)

✍ Mehdi Sayyah; Mohammad Sayyah; Hatam Boostani; Seyyed Mohammad Ghaffari; Abedin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Antimanic and mood-stabilizing effect of

Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder

✍ Athanasios Koukopoulos; Daniela Reginaldi; Giulia Serra; Alexia Koukopoulos; Gab 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Aripiprazole augmentation of incomplete

Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder

✍ Eric A. Storch; Heather Lehmkuhl; Gary R. Geffken; Alexis Touchton; Tanya K. Mur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Amisulpiride augmentation in treatment r

Amisulpiride augmentation in treatment resistant obsessive–compulsive disorder: an open trial

✍ Özmen Metin; Kemal Yazici; Senel Tot; Aylin Ertekin Yazici 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract Despite the effectiveness of clomipramine and selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive–compulsive disorder (OCD), 40% to 60% of patients who receive an adequate treatment with these agents have significant persisting symptoms. Newer atypical antipsyc